visitante ::
identificación
|
|||||||||||||||
Buscar | Enviar | Ayuda | Servicio de Bibliotecas | Sobre el DDD | Català English Español |
Página principal > Artículos > Artículos publicados > Comparison of covid-19 and non-covid-19 pneumonia in down syndrome |
Fecha: | 2021 |
Resumen: | Whether the increased risk for coronavirus disease 2019 (COVID-19) hospitalization and death observed in Down syndrome (DS) are disease specific or also occur in individuals with DS and non-COVID-19 pneumonias is unknown. This retrospective cohort study compared COVID-19 cases in persons with DS hospitalized in Spain reported to the Trisomy 21 Research Society COVID- 19 survey (n = 86) with admissions for non-COVID-19 pneumonias from a retrospective clinical database of the Spanish Ministry of Health (n = 2832 patients). In-hospital mortality rates were significantly higher for COVID-19 patients (26. 7% vs. 9. 4%), especially among individuals over 40 and patients with obesity, dementia, and/or epilepsy. The mean length of stay of deceased patients with COVID-19 was significantly shorter than in those with non-COVID-19 pneumonias. The rate of admission to an ICU in patients with DS and COVID-19 (4. 3%) was significantly lower than that reported for the general population with COVID-19. Our findings confirm that acute SARS-CoV-2 infection leads to higher mortality than non-COVID-19 pneumonias in individuals with DS, especially among adults over 40 and those with specific comorbidities. However, differences in access to respiratory support might also account for some of the heightened mortality of individuals with DS with COVID-19. |
Ayudas: | Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR00519 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR926 Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR138 Agencia Estatal de Investigación PID2019-110755RBI00/AEI/10.13039/501100011033 Agencia Estatal de Investigación CEX2018-000782-M Ministerio de Asuntos Económicos y Transformación Digital PID2019-106814RB-I00 Ministerio de Asuntos Económicos y Transformación Digital PGC2018-097019-B-I00 European Commission. Horizon 2020 848077 Instituto de Salud Carlos III PI19/00634 Instituto de Salud Carlos III PT17/0009/0014 Fundació la Marató de TV3 2016/20-30 |
Nota: | Altres ajuts: Jerôme Lejeune Foundation (No 2002, 1777-2018); NIH (1R01EB 028159-01) ; Ministerio de Ciencia e Innovación; Centros de Excelencia Severo Ochoa; CERCA Programme/Generalitat de Catalunya; CIBER of Rare Diseases (CIBERER); CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN); Fondo Europeo de Desarrollo Regional (FEDER); HERCULES Center (NIEHS P30ES019776); LuMind IDSC Foundation. |
Derechos: | Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original. |
Lengua: | Anglès |
Documento: | Article ; recerca ; Versió publicada |
Materia: | Down syndrome ; COVID-19 ; SARS-CoV-2 ; Pneumonia |
Publicado en: | Journal of clinical medicine, Vol. 10 Núm. 16 (february 2021) , p. 3748, ISSN 2077-0383 |
11 p, 712.3 KB |